PATTERN AND DRUG SENSITIVITY OF NON-SPECIFIC BACTERIAL POPULATION IN TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE

Tuberculosis and lung diseases, 2019

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.21292/2075-1230-2019-97-9-11-16
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The objective: to study the patterns of nonspecific bacterial population isolated in patients with multiple drug resistant tuberculosis in the city of Karaganda and assess its sensitivity to antimicrobial agents. Subjects and methods. 343 sputum specimens were tested. Microorganisms were identified using mass spectrometry using the MALDI-TOF method (Microflex, BD, Germany). Drug susceptibility was determined by the diffusion method in accordance with CLSI recommendations (2012). Results. Bacterial growth was observed in 20.99%. More than ⅔ of isolated microorganisms were resistant to three groups of drugs and more, thus it could be classified as MDR. S. aureus prevailed in the structure of secondary bacterial population and made 22.22%, of which 12.5% were MRSA. Among gram-negative bacteria, K. pneumoniae – 12.5% and A. baumannii – 11.11% dominated among isolated species. 10% of K. pneumonia strains and from 40 to 70% of A. baumannii were resistant to carbapenems. The secondary bacterial population isolated in pulmonary tuberculosis is represented by nosocomial strains of ESKAPE group, which are typically resistant to modern drugs.